258 related articles for article (PubMed ID: 11443221)
21. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
[TBL] [Abstract][Full Text] [Related]
22. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
23. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.
Bacallao K; Leon L; Gabler F; Soto E; Romero C; Valladares L; Vega M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):163-9. PubMed ID: 18467089
[TBL] [Abstract][Full Text] [Related]
24. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
[TBL] [Abstract][Full Text] [Related]
25. Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
Zakharov V; Lin HK; Azzarello J; McMeekin S; Moore KN; Penning TM; Fung KM
Int J Clin Exp Pathol; 2010 Jul; 3(6):608-17. PubMed ID: 20661409
[TBL] [Abstract][Full Text] [Related]
26. Loss of estrogen inactivation in colonic cancer.
English MA; Kane KF; Cruickshank N; Langman MJ; Stewart PM; Hewison M
J Clin Endocrinol Metab; 1999 Jun; 84(6):2080-5. PubMed ID: 10372714
[TBL] [Abstract][Full Text] [Related]
27. Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters.
Han B; Li S; Song D; Poisson-Paré D; Liu G; Luu-The V; Ouellet J; Li S; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):194-200. PubMed ID: 18996480
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.
Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747
[TBL] [Abstract][Full Text] [Related]
29. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
30. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
31. Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence.
Gunnarsson C; Olsson BM; Stål O;
Cancer Res; 2001 Dec; 61(23):8448-51. PubMed ID: 11731426
[TBL] [Abstract][Full Text] [Related]
32. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12.
Sakurai N; Miki Y; Suzuki T; Watanabe K; Narita T; Ando K; Yung TM; Aoki D; Sasano H; Handa H
J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):174-81. PubMed ID: 16621523
[TBL] [Abstract][Full Text] [Related]
33. 17Beta-hydroxysteroid dehydrogenases in human bone cells.
Dong Y; Qiu QQ; Debear J; Lathrop WF; Bertolini DR; Tamburini PP
J Bone Miner Res; 1998 Oct; 13(10):1539-46. PubMed ID: 9783542
[TBL] [Abstract][Full Text] [Related]
34. Expression of 17beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe.
Stoffel-Wagner B; Watzka M; Steckelbroeck S; Schramm J; Bidlingmaier JF; Klingmüller D
J Endocrinol; 1999 Jan; 160(1):119-26. PubMed ID: 9854183
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of 17beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines.
Husen B; Psonka N; Jacob-Meisel M; Keil C; Rune GM
J Mol Endocrinol; 2000 Feb; 24(1):135-44. PubMed ID: 10657005
[TBL] [Abstract][Full Text] [Related]
36. Differential estrogenic 17beta-hydroxysteroid dehydrogenase activity and type 12 17beta-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes.
Bellemare V; Laberge P; Noël S; Tchernof A; Luu-The V
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):129-34. PubMed ID: 19429442
[TBL] [Abstract][Full Text] [Related]
37. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
38. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.
Motohara K; Tashiro H; Taura Y; Ohba T; Katabuchi H
Med Mol Morphol; 2010 Dec; 43(4):197-203. PubMed ID: 21267695
[TBL] [Abstract][Full Text] [Related]
40. 17Beta-hydroxysteroid dehydrogenase type 2 and dehydroepiandrosterone sulfotransferase in the human liver.
Narasaka T; Moriya T; Endoh M; Suzuki T; Shizawa S; Mizokami Y; Matsuoka T; Sasano H
Endocr J; 2000 Dec; 47(6):697-705. PubMed ID: 11228044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
